4.4 Article

Application of multidimensional scaling to quantify shape in Alzheimer's disease and its correlation with Mini Mental State Examination: A feasibility study

期刊

JOURNAL OF NEUROSCIENCE METHODS
卷 194, 期 2, 页码 380-385

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneumeth.2010.10.019

关键词

Shape; Multidimensional scaling; Alzheimer's disease; Mini Mental State Exam; Image registration

资金

  1. Ministry of Education, Science and Technology [20100023233]
  2. Business for Cooperative R&D between Industry, Academy, and Research Institute [0850110]
  3. Ministry of Knowledge Economy of Korea [10030091]
  4. National Institutes of Health [U01 AG024904]
  5. Alzheimer's Disease Neuroimaging Initiative (ADNI)
  6. National Institute on Aging
  7. National Institute of Biomedical Imaging and Bioengineering
  8. Abbott, AstraZeneca AB
  9. Bayer Schering Pharma AG
  10. Bristol-Myers Squibb
  11. Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare
  12. GlaxoSmithKline, Infogenetics
  13. Johnson and Johnson, Eli Lilly and Co.
  14. Medpace, Inc.
  15. Merck and Co., Inc.
  16. Novartis AG
  17. Pfizer Inc.
  18. F. Hoffman-La Roche, Schering-Plough. Synarc, Inc.
  19. Alzheimer's Association and Alzheimer's Drug Discovery Foundation
  20. U.S. Food and Drug Administration
  21. NIH [P30 AG010129, K01 AG030514]
  22. Dana Foundation
  23. Korea Evaluation Institute of Industrial Technology (KEIT) [10030091] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  24. National Research Foundation of Korea [2010-0023233] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Today, high-resolution MRI scans are able to reveal even the fine details of brain structure. Several methods have been developed to quantify shape differences specific to scans of diseased brains. We have developed a novel method for quantifying shape information based on multidimensional scaling (MDS), a well-known statistical tool. Multidimensional scaling uses distance measures computed from pair-wise image registration of the training set. Image registration establishes spatial correspondence between scans in order to compare them in the same spatial framework. Our novel method has several advantages, including robustness to errors in registrations. Applying our method to 44 brain MR's showed clear separation between normal and Alzheimer scans. Using our method as basis for classification between normal and Alzheimer scans yielded better performance results compared with using the volume of hippocampus as basis for classification. We also devised a simple measure derived from the MDS approach that was shown to correlate with the Mini Mental State Examination (MMSE), a well-known cognitive test for Alzheimer's disease. (C) 2010 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据